www.fdanews.com/articles/186513-mobidiag-earns-ce-mark-for-two-tests
Mobidiag Earns CE Mark for Two Tests
April 20, 2018
Mobidiag gained CE Marking for its Amplidiag CarbaR+MCR and its Novidiag Bacterial GE+ tests.
The Amplidiag test detects the main carbapanemase-producing organism and colistin resistance markers. The Novidiag test identifies the most common enteric pathogens directly from stool samples.
The Amplidiag CarbaR+MCR enables the screening of multidrug-resistance organisms to help prevent their spread in hospitals. It can provide results in hours instead of the several days required for culture-based screening methods.